Hola.
Administre la información médica de su hijo y comuníquese con el equipo médico de Arkansas Children's por Internet.
Iniciar sesión InscribirseArkansas Children's Hospital
Información general 501-364-1100
Arkansas Children's Northwest
Información general 479-725-6800
* "By the Numbers" data for January 1, 2022 - December 31, 2022, in line with the last U.S. News and World Report Survey
"I practice at Arkansas Children's not only because it is home for me but because I'm surrounded by a team deeply committed to the children we serve. We all strive to ensure families feel confident in the care their child receives. Through this collaboration, I know we are providing excellent, compassionate care every day. I'm proud to have trained here and to be part of this team."
Virginia Erin Willis, M.D.
Pediatric neurologist, Arkansas Children’s Hospital
Chief of neurology
John H. Bornhofen, M.D. Endowed Chair in child neurology
Associate professor of pediatrics, University of Arkansas for Medical Sciences
Read Wesley Benham's story. He is a pediatric patient in Arkansas and one of only about 25 children in the United States to receive the FDA-approved gene therapy called Elevidys.
Arkansas Children’s Hospital (ACH) neurosurgeons performed close to 30 surgeries with Robotic Operating Surgical Assistant (ROSA) ONE Brain. On Jan. 23, 2023, the team placed the first deep brain stimulation (DBS) implant with ROSA.
Status migrainosus can result in missed school days and ER visits. Learn how an outpatient infusion protocol at Arkansas Children's helps streamline care and reduce ER visits.
The Rise and Walk neurorehabilitation machine safely allows children to practice the repetitive therapeutic movements vital for neuroplasticity and motor learning.
Gene therapy is changing future outlooks for Duchenne Muscular Dystrophy (DMD) patients.